THBS1 and neoplasm: These results suggest that cyclic PSAP peptide reactivates the anti-tumor mechanism in the tumor microenvironment by stimulating the expression of TSP-1, providing a new and efficient therapeutic strategy for the treatment of metastatic ovarian cancer [160] (Figure 6).